T3 Defense CEO Menachem Shalom Makes $1.7M Personal Investment in BiomX Following Zorronet Acquisition
DFNS sits 57% above its 52-week low of $0.421.
Summary
An amendment to a Schedule 13D reveals that Menachem Shalom, CEO of T3 Defense Inc., personally invested $1.7 million in BiomX Inc. shares following the acquisition of Zorronet, signaling strong insider confidence.
Key Events · Ownership and Investor Activity · DFNS
-
Significant Insider Purchase
Menachem Shalom, CEO of T3 Defense Inc., personally acquired 300,000 shares of BiomX Common Stock for a total of $1.7 million from his personal savings.
-
Updated Ownership Stake
Menachem Shalom now beneficially owns 1,600,000 shares, representing 20.4% of BiomX Inc. on a fully-diluted basis. Water IO Ltd., Star 26 Capital Inc., and T3 Defense Inc. each report shared beneficial ownership of 1,300,000 shares, or 16.57%.
-
Clarification on Zorronet Acquisition Terms
Water IO Ltd. received 1,300,000 shares of BiomX Common Stock and a $1,250,000 non-convertible promissory note as consideration for the sale of Zorronet.
Analysis · DFNS · Life Sciences
This Schedule 13D/A provides an update to the previously disclosed acquisition of Zorronet by BiomX Inc. The most significant new information is the substantial personal investment by Menachem Shalom, CEO of T3 Defense Inc. (the parent company of Water IO, which sold Zorronet). His purchase of 300,000 shares for $1.7 million, representing a significant portion of BiomX's market capitalization, signals strong conviction in the combined entity's future. This insider buying, alongside the strategic acquisition, could be viewed positively by investors, despite the dilutive nature of the share issuance for the acquisition.
At the time of this filing, DFNS was trading at $0.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22M. The 52-week trading range was $0.42 to $26.21. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.